Detection of subclinical atherosclerosis and diastolic dysfunction in patients with schizophrenia
Cüneyt Ünsal,1 Mustafa Oran,2 Hande Oktay Tureli,3 Seref Alpsoy,4 Sema Yesilyurt,5 Mehtap Arslan,6 Birol Topcu,7 Osman Karakaya,8 Erhan Kurt6 1Department of Psychiatry, Namik Kemal University, School of Medicine, Tekirdag, Turkey; 2Department of Internal Medicine, Namik Kemal Unive...
Guardado en:
Autores principales: | Ünsal C, Oran M, Tureli HO, Alpsoy S, Yeşilyurt S, Arslan M, Topcu B, Karakaya O, Kurt E |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/26ad6cd5655e47e3bce65dd42b057810 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine
por: Ünsal C, et al.
Publicado: (2013) -
Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis
por: Peluso R, et al.
Publicado: (2019) -
A Nomogram for Identifying Subclinical Atherosclerosis in Chronic Kidney Disease
por: Xiong J, et al.
Publicado: (2021) -
Subclinical Left Ventricular Dysfunction During Chemotherapy
por: Martin Nicol, et al.
Publicado: (2019) -
Factors for remodeling and diastolic myocardial dysfunction in postmenopausal women with diabetes and hypertension
por: O S Elsukova, et al.
Publicado: (2013)